<DOC>
	<DOC>NCT00829088</DOC>
	<brief_summary>The aim of this study is to get information about absorption, distribution, metabolism and excretion as well as the tolerability and safety of AZD2066 in healthy male volunteers.</brief_summary>
	<brief_title>Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066</brief_title>
	<detailed_description />
	<criteria>Provision of signed informed consent Clinically normal physical findings and laboratory values as judged by the investigator and a normal resting ECG. History of somatic disease/condition, which may interfere with the objectives of the study. History of previous or ongoing psychiatric disease/condition including psychosis, affective disorder, anxiety disorder, borderline state and personality disorder. Healthy volunteers who have been exposed to radiation levels above background (eg, through Xray examinations).</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Mass balance</keyword>
	<keyword>AZD2066</keyword>
	<keyword>Pain</keyword>
	<keyword>Pain conditions</keyword>
</DOC>